- Report
- March 2026
- 142 Pages
Global
From €4351EUR$4,850USD£3,719GBP
- Report
- March 2026
- 145 Pages
Global
From €4351EUR$4,850USD£3,719GBP
- Report
- March 2026
- 135 Pages
Global
From €4351EUR$4,850USD£3,719GBP
- Report
- March 2026
- 140 Pages
Global
From €4351EUR$4,850USD£3,719GBP
- Report
- March 2026
- 209 Pages
Global
From €4440EUR$4,950USD£3,796GBP
- Report
- March 2026
- 135 Pages
Global
From €4351EUR$4,850USD£3,719GBP
- Report
- February 2026
- 146 Pages
Global
From €4351EUR$4,850USD£3,719GBP
- Report
- February 2026
- 299 Pages
Global
From €4979EUR$5,550USD£4,256GBP
- Report
- February 2026
- 250 Pages
Global
From €4028EUR$4,490USD£3,443GBP
- Report
- February 2026
- 260 Pages
Global
From €3241EUR$3,613USD£2,770GBP
€3812EUR$4,250USD£3,259GBP
- Report
- February 2026
- 140 Pages
Global
From €4351EUR$4,850USD£3,719GBP
- Report
- February 2026
- 140 Pages
Global
From €4351EUR$4,850USD£3,719GBP
- Report
- February 2026
- 185 Pages
Global
From €4440EUR$4,950USD£3,796GBP
- Report
- February 2026
- 101 Pages
Global
From €3095EUR$3,450USD£2,646GBP
- Report
- February 2026
- 229 Pages
Global
From €4171EUR$4,650USD£3,566GBP
- Report
- February 2026
- 152 Pages
Global
From €4351EUR$4,850USD£3,719GBP
- Report
- February 2026
- 210 Pages
Global
From €3241EUR$3,613USD£2,770GBP
€3812EUR$4,250USD£3,259GBP
- Report
- January 2026
- 190 Pages
Global
From €4440EUR$4,950USD£3,796GBP
- Report
- January 2026
- 97 Pages
Global
From €3095EUR$3,450USD£2,646GBP
- Report
- January 2026
- 150 Pages
Global
From €4351EUR$4,850USD£3,719GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more